Professor Jennifer Whitwell shares her thoughts on Progressive Supranuclear Palsy (PSP), the role Neuroimaging can play when combining modalities to support more effective diagnosis of this complex condition.
Table of Contents:
00:00 - Introductions
01:48 - Progressive Supranuclear Palsy
05:28 - Neuroimaging Modalities
19:27 - Correlations between Modalities
33:13 - Summary
34:24 - Q&A
About the presenter: The main research goal of Jennifer Whitwell, Ph.D., is to use neuroimaging to increase understanding of how the brain changes in patients with a range of different neurodegenerative diseases, particularly frontotemporal dementia, progressive supranuclear palsy, apraxia of speech, primary progressive aphasia and atypical presentations of Alzheimer's disease. She utilizes magnetic resonance imaging (MRI) and positron emission tomography (PET) scans to assess structural and functional changes in the brain and determine how these changes are related to clinical symptoms and disease progression. Dr. Whitwell's research is funded by the National Institutes of Health and the Alzheimer's Association.
